| Dr Anayda Dejesus-cruz, MD | |
|
687 N Main St, Attleboro, MA 02703-1518 | |
| (508) 222-3200 | |
| (508) 222-7034 |
| Full Name | Dr Anayda Dejesus-cruz |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 33 Years |
| Location | 687 N Main St, Attleboro, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083665012 | NPI | - | NPPES |
| 3203263 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 159774 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sturdy Memorial Hospital | Attleboro, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sturdy Memorial Associates Inc | 9537152806 | 177 |
News Archive
A toxin produced by a bacterium that causes urinary tract infections is related to, yet different in key ways from, the toxin that causes whooping cough, according to new research.
Recovery after a stroke is often challenging, and patients are also at heightened risk of another stroke. Now, with the launch of a new clinical trial, stroke survivors across the country will have the opportunity to help guide how future patients are cared for after a stroke.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
› Verified 5 days ago
| Entity Name | Sturdy Memorial Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649596354 PECOS PAC ID: 9537152806 Enrollment ID: O20100629000756 |
News Archive
A toxin produced by a bacterium that causes urinary tract infections is related to, yet different in key ways from, the toxin that causes whooping cough, according to new research.
Recovery after a stroke is often challenging, and patients are also at heightened risk of another stroke. Now, with the launch of a new clinical trial, stroke survivors across the country will have the opportunity to help guide how future patients are cared for after a stroke.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
› Verified 5 days ago
| Entity Name | Riverbend Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841651197 PECOS PAC ID: 5698064343 Enrollment ID: O20160614001710 |
News Archive
A toxin produced by a bacterium that causes urinary tract infections is related to, yet different in key ways from, the toxin that causes whooping cough, according to new research.
Recovery after a stroke is often challenging, and patients are also at heightened risk of another stroke. Now, with the launch of a new clinical trial, stroke survivors across the country will have the opportunity to help guide how future patients are cared for after a stroke.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Anayda Dejesus-cruz, MD 17 Stanley Rd, Norton, MA 02766-2921 Ph: (508) 222-3200 | Dr Anayda Dejesus-cruz, MD 687 N Main St, Attleboro, MA 02703-1518 Ph: (508) 222-3200 |
News Archive
A toxin produced by a bacterium that causes urinary tract infections is related to, yet different in key ways from, the toxin that causes whooping cough, according to new research.
Recovery after a stroke is often challenging, and patients are also at heightened risk of another stroke. Now, with the launch of a new clinical trial, stroke survivors across the country will have the opportunity to help guide how future patients are cared for after a stroke.
Forensic DNA profiling has become a standard tool in the search for missing people in the aftermath of mass violence and disaster, but until now there has been very little effort to identify and analyze the major ethical and policy challenges associated with this new use of genetic technology.
MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.
› Verified 5 days ago
Dr. Eugene Digiovanni, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 687 N Main St, Attleboro, MA 02703 Phone: 508-222-3200 Fax: 508-223-4810 | |
Elizabeth Ann Moore, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 211 Park St, Attleboro, MA 02703 Phone: 508-222-5200 Fax: 508-236-7909 | |
Ms. Carolyn Lipsky, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 687 N Main St, Attleboro, MA 02703 Phone: 508-222-3200 | |
Ms. Maryellen Doherty, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 687 N Main St, Attleboro, MA 02703 Phone: 508-222-3200 | |
Dr. Diana Calogrias, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 687 N Main St, Attleboro, MA 02703 Phone: 508-222-3200 Fax: 508-222-7034 | |
Dr. Matthew J Rogalski, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 687 N Main St, Attleboro, MA 02703 Phone: 508-222-3200 Fax: 508-222-7034 |